Search research articles
Contact Us
Filters
Showing results (251-260 of 265) with videos related to
Page
of 27
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 19, 2007
Prostate cancer early detection. Clinical practice guidelines in oncology
Mark H Kawachi, Robert R Bahnson, Michael Barry, et al.
European Urology Focus
|
December 12, 2024
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial
Tarek Ajami, Hui Yu, Joao G Porto, et al.
European Urology
|
January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Matthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
European Urology
|
May 23, 2017
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens
Paul L Nguyen, Zaid Haddad, Ashley E Ross, et al.
European Urology
|
June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
Sarah Burdett, David J Fisher, Jayne F Tierney, et al.
The Journal of Urology
|
June 20, 2025
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial
Pedro F S Freitas, Archan Khandekar, Joao G Porto, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
Cancer Genetics
|
September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)
Nishwant Swami, William L Hwang, Jimmy A Guo, et al.
European Urology
|
December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials
Todd M Morgan, Yi Ren, Siyi Tang, et al.
JAMA Oncology
|
February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
Felix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 265) with videos related to
Sort By:
Page
of 27
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 19, 2007
Prostate cancer early detection. Clinical practice guidelines in oncology
Mark H Kawachi, Robert R Bahnson, Michael Barry, et al.
European Urology Focus
|
December 12, 2024
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial
Tarek Ajami, Hui Yu, Joao G Porto, et al.
European Urology
|
January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Matthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
European Urology
|
May 23, 2017
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens
Paul L Nguyen, Zaid Haddad, Ashley E Ross, et al.
European Urology
|
June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
Sarah Burdett, David J Fisher, Jayne F Tierney, et al.
The Journal of Urology
|
June 20, 2025
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial
Pedro F S Freitas, Archan Khandekar, Joao G Porto, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
Cancer Genetics
|
September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)
Nishwant Swami, William L Hwang, Jimmy A Guo, et al.
European Urology
|
December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials
Todd M Morgan, Yi Ren, Siyi Tang, et al.
JAMA Oncology
|
February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
Felix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.
Page
of 27